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Abstract 
Aims: In ventricular myocytes from humans and large mammals, the transverse and axial tubular system (TATS) 
network is less extensive than in rodents with consequently a greater proportion of ryanodine receptors (RyRs) 
not coupled to this membrane system. TATS remodeling in heart failure (HF) and after myocardial infarction (MI) 
increases the fraction of non-coupled RyR. Here we investigate whether this remodeling alters the activity of 
coupled and non-coupled RyR sub-populations through changes in local signaling. We study myocytes from 
patients with end-stage heart failure (HF), compared to non-failing (non-HF), and myocytes from pigs with MI 
and reduced left ventricular (LV) function, compared to sham intervention (SHAM). 
Methods and Results: Single LV myocytes for functional studies were isolated according to standard protocols. 
Immunofluorescent staining visualized organization of TATS and RyRs. Ca2+ was measured by confocal imaging 
(fluo-4 as indicator) and using whole cell patch clamp (37 °C). Spontaneous Ca2+ release events, Ca2+ sparks, as a 
readout for RyR activity were recorded during a 15 s period following conditioning stimulation at 2 Hz. Sparks 
were assigned to cell regions categorized as coupled or non-coupled sites according to a previously developed 
method. Human HF myocytes had more non-coupled sites and these had more spontaneous activity than in non-
HF. Hyperactivity of these non-coupled RyRs was reduced by calcium-calmodulin-dependent kinase II (CaMKII) 
inhibition. Myocytes from MI pigs had similar changes compared to sham controls as seen in human HF myocytes. 
As well as by CaMKII inhibition, in MI, the increased activity of non-coupled sites was inhibited by mitochondrial 
ROS (mito-ROS) scavenging. Under adrenergic stimulation, Ca2+ waves were more frequent and originated at 
non-coupled sites, generating larger Na+/Ca2+ exchange currents in MI than in SHAM. Inhibition of CaMKII or 
mito-ROS scavenging reduced spontaneous Ca2+ waves, and improved excitation-contraction coupling.  
Conclusions: In HF and after MI, RyR microdomain re-organization enhances spontaneous Ca2+ release at non-
coupled sites in a manner dependent on CaMKII activation and mito-ROS production. This specific modulation 
generates a substrate for arrhythmia that appears to be responsive to selective pharmacologic modulation. 
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Introduction 
Abnormal cellular Ca2+ handling and excitation-contraction coupling contribute to reduced contractile function 
and arrhythmogenesis in heart failure (HF) 1. Ca2+ uptake into the sarcoplasmic reticulum (SR) by SERCA, Ca2+ 
release through ryanodine receptors (RyR), Ca2+ extrusion across the sarcolemma by the Na+/Ca2+ exchange 
(NCX), and Ca2+ influx via L-type Ca2+ channels (LTCC) all contribute to this process. Novel Ca2+ pathways also 
emerge such as flux through TRP channels 2. Functional changes in Ca2+ handling occur through alteration in 
protein expression or through post-translational modifications. Signaling pathways involved in remodeling of 
Ca2+ handling include those mediated by reactive oxygen species (ROS), Ca2+/calmodulin-dependent kinase II 
(CaMKII) and nitric oxide (NO). Loss of SR Ca2+ through ’leaky’ RyRs is attributed to post-translational 
modifications of RyRs that lead to alterations in RyR Ca2+ sensitivity and open probability (Po). In animal models 
of disease, increased SR Ca2+ leak is observed after myocardial infarction (MI) compared to control 3 as well as in 
HF 4, diabetes 5 and atrial fibrillation (AF) 6. In human myocytes, greater Ca2+ leak was reported in HF 7 and AF 8,9 
although one study found that spontaneous release events, Ca2+ sparks, were less frequent in HF 10.  Ca2+ loss 
through RyRs reduces contraction by decreasing the SR Ca2+ content, and can be a trigger to induce 
arrhythmogenic Ca2+ waves through activation of NCX. 
Changes in the subcellular architecture of cardiac myocytes with disease further modulate Ca2+ handling. 
Reduced density and disorganization of the transverse and axial tubular system (TATS) is seen in post-MI 
remodeling 11–13. These, and other data suggest that TATS remodeling is a general feature in the progression to 
HF 14. In contrast, RyR clusters appear to remain distributed at the Z lines throughout the cell, resulting in a large 
fraction of RyRs that are no longer in close proximity to the sarcolemmal (SL) membrane and TATS, i.e. outside 
couplons. Due to the increased distance to LTCCs, these non-coupled RyRs cannot be activated directly by Ca2+ 
entry via LTCC but are activated with a delay through Ca2+-induced-Ca2+-release propagating from coupled sites. 
This dys-synchrony reduces the rise time and amplitude of the global Ca2+ transient 12,15–17 and contributes to 
impaired contractile function.  
The architecture of TATS results in different signaling microdomains around coupled and non-coupled RyR. In 
healthy pig myocytes, coupled RyRs have a unique NOX2- and CaMKII-dependent regulation during increased 
heart rate and β-adrenergic stimulation 18,19. However, the link between TATS remodeling in disease and the 
modulation of the larger population of non-coupled RyR is not well studied. 
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To date, changes in RyR function in human HF have been exclusively studied at the myocyte level 7,20, without 
information on subpopulations of RyRs, and mostly using HF myocytes only. Comparisons between non-HF and 
HF are scarce 10. Recent work studied RyRs extracted from LV tissues samples from HF and non-HF and 
reconstituted in bilayers 21. In the pig with MI, we reported that TATS remodeling affected properties of the RyR 
subpopulations but did not investigate the signaling mechanisms involved 22. In a dog model of HF, Belevych et 
al. found that RyR subpopulations had different characteristics 23. However, little is known of the intrinsic 
properties, modulation and arrhythmogenic contributions of coupled vs. non-coupled RyRs in post-MI 
remodeling or in human HF. Yet, selective targeting of modulators controlling RyR Po has become of interest in 
the treatment of cardiac disease where impaired Ca2+ handling plays a role 24–26.  
Pilot data from our earlier work indicated that after MI, increased spontaneous RyR activity was exclusively a 
feature of non-coupled sites. However, no mechanistic explanation could be offered at the time 19. The present 
study was designed: (1) to explore and validate the relevance of differences in coupled and non-coupled RyR 
properties in human HF; (2) to study underlying mechanisms of the modulation of RyR subpopulations and the 
arrhythmogenic consequences in post-MI remodeling. Unlike in earlier work, here we induced MI in the anterior 
wall 27, which has a larger impact on left ventricular (LV) remodeling than MI in the posterior wall 15,22. 
Downloaded from https://academic.oup.com/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvy088/4970798
by University of Glasgow user
on 08 May 2018
4 
 
Methods 
Permission for the use of tissue from human hearts in the heart transplantation program, explants and non-used 
donor hearts, was obtained from the Ethical Committee of the University Hospital (UZ Leuven) with permit 
number S58824. For use of this residual tissue, no additional informed consent was needed and the study 
conforms to the Helsinki declaration. Patients received usual care HF medication and data can be found in 
Supplemental Tables 1 & 2. 
Animals were housed and treated according to the Guide for the Care and Use of Laboratory Animals (National 
Institute of Health, USA), the European Directive 2010/63/EU and experimental protocols were approved by the 
in-house ethical committee (Ethische Commissie Dierproeven, KU Leuven), with permit numbers P10139, P14176 
and P16110. 
Cell isolation, confocal microscopy, and electrophysiological recordings were performed as previously described 
19. Single LV myocytes were enzymatically isolated from explanted human hearts 28 (failing, HF, and non-failing, 
non-HF) and from pigs with MI in the anteroseptal region, with reduced LV function and cellular remodeling 19,27 
(Supplemental Figure 1 & 2). In human hearts, myocytes were obtained from the territory of the left anterior 
descendens coronary artery (LAD), cannulating a diagonal side-branch. If the LAD was not accessible, the left 
circumflex branch was used. In MI pigs, myocytes from the peri-infarct regions were prepared by cannulating a 
LAD side-branch and the same region was selected in sham animals. We used low (0.5 Hz) and high (2 Hz) 
frequency stimulation in the whole-cell voltage-clamp mode (-70 to +10 mV); the Ca2+ indicator fluo-4 was 
included in the pipette solution. Ca2+ sparks were recorded for 15 s after stimulation during confocal line-scan 
imaging. Cells were scanned along the longitudinal axis, orthogonal to the Z lines, avoiding scanning through 
nuclei. All experiments were performed at 37 °C. Ca2+ sparks were assigned to coupled/non-coupled release sites 
based on an established algorithm 19. A per-pixel spark frequency was calculated and normalized to give a 
measure in sparks/100 μm/s. Spark frequency was normalized to the length of the line in coupled/non-coupled 
sites. Ca2+ waves were induced at 2 Hz stimulation in the presence of isoproterenol (ISO; 10 nM). Ca2+ wave 
incidence was normalized to number of waves/100 µm/s and wave origins (pixel-based) were used to assign 
waves to coupled/non-coupled sites. 
Immunofluorescent imaging was performed in fixed isolated cells or tissue sections.  NCX was used as a surrogate 
marker to report on TATS membranes and distance masks were constructed as previously described 19. From 
these masks, the fraction of coupled/non-coupled RyRs was calculated and co-localization of coupled/non-
coupled RyRs with CaMKII was quantified according to the Manders’ coefficient. To study TATS in relation to 
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subcellular Ca2+ release, non-fixed myocytes were stained with wheat-germ-agglutinin-(WGA)-Alexa594 as 
described previously 19.  
Measurements of FAD/NAD(P)H for estimating redox potential were performed at 37 °C under electrical field 
stimulation at various frequencies by wide field fluorescence imaging using a Nikon TE2000 inverted microscope 
equipped with a 40 x 1.3 NA oil immersion objective and Hamamatsu Flash 4 CMOS camera. Endogenous 
fluorescent FAD and NAD(P)H signals were measured: NAD(P)H was excited at 360/10 nm and emission was 
collected at 480/40 nm (500 ms), FAD was excited at 485/20 nm and emission was collected at 535/30 nm (500 
ms). Excitation and emission filters were selected using filter wheels (Sutter) and wavelengths discriminated 
using a triple band pass dichroic filter. Images were collected at a frequency of ratio pair every 20 seconds.  
 
Statistics 
All data are presented as means ± SEM. For statistical analysis, we used a nested design taking into account n 
cells and N animals (freeware program R), and Student’s t-test or a 2-way ANOVA with Bonferroni post hoc testing 
as applicable. The Fisher’s exact test was used to compare incidence of Ca2+ waves between different groups. 
Data were considered significantly different when the probability value was < 0.05. 
 
Detailed methods are provided in the Online Supplement.    
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Results 
Myocyte hypertrophy and increased fraction of non-coupled release sites in human HF 
HF myocytes were longer than non-HF, without difference in cell width (Figure 1A). The density of TATS was 
significantly lower in HF myocytes and axial tubules were more abundant (Figure 1A).  
To identify RyR subpopulations in human myocytes, we used a previously described algorithm 19, establishing 
criteria as shown in the Online Supplement (Supplemental Figure 3A). These pre-established criteria allow 
studying of coupled and non-coupled release sites in a more rigorous way than used previously 22,23, excluding 
intermediate release sites (between > 0.5 µm and < 2 µm) (Supplemental Figure 4). This approach still includes 
on average 80% of all release sites in all groups. As shown by its rightward shift, the distribution of the time to 
half-maximum of the Ca2+ transient (TF50) for all release sites was significantly increased in HF myocytes (Figure 
1B, middle). Quantification of early (coupled) and late (non-coupled) sites confirmed the decrease in the number 
of coupled sites and the increase of non-coupled sites in HF (Figure 1B, right). These data indicate that in human 
HF, hypertrophy is associated with an altered TAT network and increasing increased proportion of non-coupled 
release sites. 
 
Increased activity of non-coupled release sites in HF, dependent on CaMKII 
In non-HF myocytes, high-frequency stimulation caused a 3-fold increase in spark frequency in coupled sites 
compared to that observed under low frequency stimulation, whereas the spark frequency was only increased 
by 1.5-fold in non-coupled release sites (Figure 1C, middle). In HF myocytes, this frequency-dependent response 
was absent at coupled sites (Figure 1C, right), despite a substantial increase in SR Ca2+ load at 2 Hz (Figure 2B) in 
both HF and non-HF; in HF SR Ca2+ content tended to be lower. In contrast, frequency of sparks at non-coupled 
sites in HF myocytes was significantly increased at 2 Hz (Figure 1C, right). The specific CaMKII inhibitor AIP 
significantly reduced this hyperactivity in non-coupled regions without affecting spark frequency at coupled sites 
(Figure 2A).  
 
Slower and smaller global Ca2+ transients in HF with beneficial effect of CaMKII inhibition  
A reduced synchrony of Ca2+ release has previously been shown to lead to a slower rise of the Ca2+ transient in 
human HF myocytes 17. Here we confirm that an increased fraction of non-coupled sites in HF myocytes leads to 
a slower upstroke and reduced amplitude of the Ca2+ transient (Figure 2B). This dys-synchrony is further 
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illustrated by the delay in the fraction of the scan line that reached half-maximal Ca2+ release in HF myocytes 
compared to non-HF. Interestingly, inhibition of CaMKII that reduces diastolic release, actually removes the 
difference between HF and non-HF for amplitude and rate of upstroke (Figure 2C).  
 
Specific modulation of coupled sites is lost after MI, whereas a de-novo regulation appears at non-
coupled release sites  
Having established remodeling of TATS and spark properties in human HF, we used the post-MI pig model to gain 
further mechanistic understanding. The pig shares many features of cardiac physiology with humans, and 
ischemic cardiomyopathy is the major cause of human HF. The relevance of the pig MI model is further 
underscored by earlier pilot data indicating that the properties of coupled and non-coupled release sites and 
CaMKII dependence was similar to human HF 19.  
Indeed, in MI myocytes in the present study, the CaMKII inhibitor AIP did not affect the spark frequency in 
coupled sites (Figure 3A), but reduced the spark frequency in non-coupled release sites (Figure 3B and 
Supplemental Figure 5A for baseline data). Global Ca2+ transients in these MI myocytes were smaller with 
reduced rate of upstroke, as in HF, and consistent with the loss of TATS and reduced synchrony of Ca2+ release 
(Supplemental Figure 5B).  
We further examined signaling and microdomains in the RyR subpopulations focusing on ROS as candidate for 
post-MI signaling. NOX2 signaling is known to change in cardiac disease 29 and could be affected because of the 
TATS remodeling, while changes in metabolism and mitochondrial function 27 could affect mito-ROS production. 
In contrast to SHAM myocytes, inhibition of NOX2 with gp91 ds-tat peptide, did not affect the spark frequency 
in coupled sites after MI (Figure 3A). Since non-coupled sites lack TATS, NOX2-generated ROS at the TAT 
membrane is unlikely to affect non-coupled RyRs as confirmed by the lack of an effect of gp91 application 
(Supplemental Figure 6). Using the global ROS scavenger, NAC, we probed for ROS-mediated modulation from 
other sources. NAC significantly reduced the spark frequency in non-coupled sites (Figure 3B). None of these 
interventions affected the SR Ca2+ load (Supplemental Figure 7B & C).  
 
CaMKII and NOX2 localization is intact after MI 
The lack of frequency-response in coupled release sites after MI could be attributed to the specific loss of CaMKII 
and/or NOX2 in coupled regions. In both SHAM and MI myocytes, there was however a similar degree of co-
localization between CaMKII and coupled or non-coupled RyRs (Figure 4Aa). No change in CaMKII expression in 
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SHAM and MI tissue was detected (Supplemental Figure 8). The localization of NOX2 at the TATS was intact after 
MI (Figure 4Ab, Supplemental Figure 9A & B).  
 
Reduced Ca2+ and ROS scavenging in the dyadic cleft after MI 
A potential mechanism for the lack of CaMKII activation in coupled regions after MI remodeling is the loss of high 
Ca2+ microdomains in the dyadic cleft. We analysed local [Ca2+] by measuring ICaL inactivation and local Ca2+ 
transient kinetics. The early inactivation of ICaL was decreased (larger Taufast), indicating reduced [Ca2+] near LTCC 
(Figure 4B). In addition, the amplitude and rate of upstroke of Ca2+ transients in regions of coupled sites were 
reduced (Supplemental Figure 5C).  
We tested the hypothesis that changes in NOS1 could reduce ROS in the dyadic cleft, as e.g. produced by local 
NOX2 (Figure 4C). Recently, local ROS scavenging mechanism at the SR have been described, whereby NOS1-
derived NO can scavenge xanthine oxidase (XO)-produced ROS 30. During disease, NOS1 has been shown to 
translocate from the SR to the TATS 31. Translocated NOS1-derived NO at the TATS could thus mask a local ROS 
microdomain by scavenging ROS produced by NOX2 in MI myocytes. Inhibition of NOS1 with L-NAME, and with 
the more specific L-VNIO produced a significant increase in the spark frequency in coupled sites in MI myocytes 
to a similar level as in control. NOS inhibition did not affect the frequency-response in coupled sites in SHAM 
myocytes (Figure 4C).  
 
ROS from mitochondria modulate non-coupled RyRs after MI 
The data in Figure 3B imply that there must be an alternative ROS source to NOX2, affecting the non-coupled 
sites in MI. We hypothesised that the mitochondria were responsible. Scavenging mitochondrial ROS (mito-ROS) 
using mitoTEMPO significantly reduced spark frequency at non-coupled regions in MI, without affecting coupled 
sites (Figure 5A); there was no effect in SHAM. SR content was unchanged by this maneuver in SHAM or MI 
(Supplemental Figure 7B & C). Inhibition of xanthine oxidase (XO) with oxypurinol had no effect on sparks in 
either SHAM or MI myocytes (Supplemental Figure 10) indicating that this enzyme did not contribute to ROS 
generation. These observations raised the question whether pacing at 2 Hz selectively induced mito-ROS in MI 
but not in SHAM. To test this possibility, we studied cellular redox potential through measuring the FAD/NAD(P)H 
ratio. During stimulation at 2 Hz, the NAD(P)H signal decreased while the FAD signal increased. Comparison of 
the ratio of these changes between SHAM and MI revealed a greater increase in FAD/NAD(P)H in MI myocytes 
(Figure 5Bb).  
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After MI Ca2+ waves are more frequent and originate in non-coupled release sites 
Increased RyR activity/sensitivity may result in spontaneous Ca2+ waves that promote arrhythmias. We 
investigated the susceptibility for Ca2+ waves in MI during β-adrenergic stimulation at 2 Hz, mimicking the in vivo 
adrenergic effects.  
MI myocytes exhibited more Ca2+ waves than SHAM, and these Ca2+ waves generated significantly larger NCX 
currents (INCX) (Figure 6B). This was reflected by an increased number and amplitude of DADs as well as an 
increase in number of spontaneous action potentials (APs) (Figure 6C). We related the source of Ca2+ waves to 
either coupled and non-coupled sites based on the TF50 of the Ca2+ transient. A distribution plot shows that after 
MI, Ca2+ waves originated more frequently from non-coupled sites (Figure 6D). 
To generate triggered activity, and ultimately arrhythmias, membrane depolarization by the inward INCX 
generated by the Ca2+ waves must reach the threshold for AP generation. Larger INCX is generated when multiple 
Ca2+ waves collide. In MI, more cells exhibited colliding Ca2+ waves compared to SHAM (Figure 6Ea). These 
colliding waves had a larger amplitude and INCX compared to single Ca2+ waves in MI myocytes (Supplemental 
Figure 11). Colliding waves originating from non-coupled sites had the highest peak and integrated INCX (Figure 
6Eb).  
 
Inhibition of CaMKII and mito-ROS reduces Ca2+ waves from non-coupled sites in MI 
In MI myocytes, mitoTEMPO and AIP were able to reduce the increased wave frequency originating from non-
coupled sites without significantly affecting those arising from coupled regions (Figure 7A). Direct inhibition of 
RyR opening with flecainide and S107 reduced Ca2+ waves in both MI and SHAM. 
We assessed the impact of these interventions on excitation-contraction coupling and the Ca2+ transient. 
Flecainide, CaMKII and mitoTEMPO did not affect the Ca2+ transient amplitude, whereas S107 significantly 
reduced the amplitude in both SHAM and MI myocytes (Figure 7B).   
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Discussion 
TATS remodeling in ventricular myocytes after MI and in HF, leads to an increased number of non-coupled release 
sites. Unlike in the healthy heart, these sites, outside of couplons, exhibit increased spontaneous activity during 
diastole at higher heart rates. This arises through distinct alterations in Ca2+ and ROS microdomains around the 
different RyR populations. After MI, non-coupled release sites are at the origin of Ca2+ waves. These Ca2+ waves 
generate larger depolarizing currents by simultaneously activating multiple sites, thereby highlighting the 
arrhythmogenic potential of these sites.  
 
TATS remodeling in human HF impacts on RyR activity and global Ca2+ transient properties  
We observed a significant reduction in TATS density, predominantly of the T-tubules (TTs) in HF, extending earlier 
studies in human tissue. Early electron microscopy studies described dilated TTs 32. Other features previously 
described include an irregular distribution 11,17, an increase in TT diameter 11 and a reduction in TT density 33–35.  
TATS remodeling results in an increased fraction of non-coupled RyR cluster sites, in line with data from a canine 
model of HF 36 and human HF myocytes 35. This remodeling is associated with loss of synchrony and reduced 
amplitude of the Ca2+ transient through delayed opening of the non-coupled RyRs. Similar findings were reported 
in animal models 12,13,15 but data from human HF are scarce or did not include information from non-HF myocytes 
17,35.  
The present study also adds new information regarding the intrinsic properties of RyRs clusters at coupled and 
non-coupled sites. Indeed, previous studies have only reported on overall RyR activity recorded as sparks in 
diastole and in lipid bilayer experiments, without distinguishing subpopulations 7,21,37. They mostly report an 
increase in total spark frequency, although Lindner et al. reported a decrease in HF 10. An important difference 
between the aforementioned study and ours is that we studied cells under voltage-clamp. The voltage-clamp 
mode with controlled membrane potential and equal duration of membrane depolarization achieves a more 
equal SR load and Ca2+ fluxes allowing better dissection of RyR properties with less influence of confounding 
factors (including disease associated remodeling of the action potential and RMP). Our finding that the spark 
activity in non-coupled sites is sensitive to CaMKII inhibition is in line with previous reports on RyR properties in 
HF, although a comparison to non-HF was not included in those studies 7,37. Recently, lipid bilayer experiments 
on RyR activity support these findings, with a major role for RyR phosphorylation and thiol oxidation in HF 
conditions 21. In line with the study from Fischer et al. 7, no differences in response to CaMKII inhibition were 
found between myocytes from ischemic and dilated cardiomyopathy (Supplemental Figure 12). The data 
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complement earlier work on the global assessment of Ca2+ transients in HF vs. non-HF human myocytes 38. Our 
data further show that in HF, CaMKII inhibition can reduce diastolic events with favorable effects on the global 
Ca2+ transient. 
 
Loss of dyadic cleft CaMKII signaling after MI 
Despite its presence at both coupled and non-coupled RyR clusters, we did not detect CaMKII activation in the 
dyadic cleft near coupled sites in MI, an effect possibly due to reduced [Ca2+] in this microdomain 39. This could 
be a primary event after MI with several potential causes. The SR Ca2+ content is not reduced excluding this 
possibility. Reduced coupling gain between LTCC and RyR is another possibility, as in the rabbit with HF 16,40. 
Litwin et al. 16 proposed a different molecular configuration of LTCC as the underlying mechanism whereas Bryant 
et al. reported a redistribution of ICaL away from the TT 40,41. Another possibility is the structure of the RyR cluster. 
Cluster size and organization affect Po 42,43 and may change in disease as recently reported for AF 44.  
Furthermore, Erickson et al. 45 recently reported that exposure to NO prior to Ca2+/CaM binding to CaMKII 
strongly suppresses CaMKII activity. This could explain the loss of CaMKII activation in coupled regions after MI, 
in line with the increased spark frequency with NOS inhibition. NO production may mask the ROS microdomain 
through translocation of NOS1 from the SR to the TATS. This may be through ROS in the dyadic cleft or ROS from 
mitochondrial sources.  
Another possible mechanism may be through dysregulation of localized antioxidant mechanisms. Glyceraldehyde 
3-phosphate dehydrogenase, located at the TATS 46, potentially regulates the redox state at SR-SL junctions by 
the production of NADH. In support of this notion, ischemic and dilated cardiomyopathy is known to cause a shift 
in metabolic substrate utilization from free fatty acids to glucose 27,47, thereby increasing the rate of glycolysis 
and associated NADH production, resulting in ROS scavenging at the dyadic cleft.  
 
Non-coupled release sites have increased spontaneous activity 
Our data show a de novo form of modulation of non-coupled sites, dependent on CaMKII activation and mito-
ROS. Increased CaMKII activity in the regulation of RyRs has been associated with several cardiac diseases 7,37,48,49 
but its selective activation at non-coupled regions was so far not reported. The low rate of upstroke of triggered 
Ca2+ release in non-coupled regions makes it unlikely that CaMKII is activated by Ca2+ in non-coupled regions. 
Instead, our data suggest a more prominent role for mito-ROS, rather than Ca2+, in the activation of CaMKII, as 
Downloaded from https://academic.oup.com/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvy088/4970798
by University of Glasgow user
on 08 May 2018
12 
 
recently shown in diabetic mouse heart 50. Moreover, increased levels of mito-ROS manifest in patients 51 and 
animals with advanced HF 52–54.  
The increased activity of RyRs at non-coupled sites in MI occurs without apparent change in SR Ca2+ content. We 
could not yet study the full relationship between SR leak and content 55. It is conceivable that our experiments 
occur at the exponential part of this relationship together with a shift in the curve due to the RyR post-
translational modifications. Therefore, one can have increased leak with small or no changes in SR Ca2+ content.  
 
Non-coupled sites are hotspots for arrhythmogenic Ca2+ waves 
The increased wave frequency make non-coupled RyR clusters a potential source of deleterious Ca2+ handling in 
MI. In contrast, Belevych et al. recently proposed that potential arrhythmogenic Ca2+ waves arise from coupled 
sites in myocytes from the dog with pacing-induced HF 23. This opposing finding may reflect species differences 
and different types of remodeling, as there was no loss of TT in this HF model. Also, differences in experimental 
conditions may help to explain the different findings between the two studies. Belevych et al. recorded at room 
temperature and 0.5 Hz pacing, in contrast to 37 oC and 2 Hz pacing frequency in the present study 23. Of note, 
at 0.5 Hz conditioning, we did not see the distinguishing activity between coupled and non-coupled RyR.  
Inhibition of diastolic RyR Ca2+ leak could be a therapeutic strategy with direct RyR block or modulation24–26. In 
the current study, Ca2+ waves were reduced by both RyR blockade and inhibition of RyR modulation. The S107 
and flecainide-dependent reduction in Ca2+ wave frequency is in line with data previously reported under various 
conditions 24,26, although how flecainide reduces Ca2+ waves is still debated 56.  
The role of CaMKII in arrhythmias has been previously investigated 57, including ROS-induced CaMKII activation 
58,59. Here we show that CaMKII inhibition in MI selectively reduced waves originating from non-coupled RyRs 
without adverse effects on coupled RyRs and excitation-contraction coupling. CaMKII inhibition or mito-ROS 
scavenging would thus be better strategies than direct RyR inhibition, which is less discriminating.  
Lastly, the impact of waves on depolarizing currents was larger in MI. This may at first glance be counterintuitive 
as non-coupled sites are more distant from the membrane. However, this distance may also cause a temporary 
increased re-circulation of Ca2+ in the stores with eventually larger cell-wide Ca2+ release, colliding waves, larger 
INCX, and ultimately, triggered activity. In vivo monophasic AP from the peri-infarct region during 2 Hz pacing and 
isoproterenol support the occurrence of high amplitude delayed-afterdepolarizations (DADs) (Supplemental 
Figure 13), whereas only low amplitude DADs were observed in SHAM animals. In 3 out of 5 MI pigs, this pro-
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arrhythmic pacing protocol triggered premature ventricular complexes in vivo. This was rarely observed in SHAM 
animals.   
 
Limitations and future directions 
Human samples are limited in nature and quantity and not available for all experiments. Nevertheless, our key 
observations in pig suggest comparable mechanisms after disease remodeling in human HF myocytes.   
In the present study, only indirect and global ROS measurements were used although development of local ROS 
measurements could provide further insights. For local [Ca2+], targeted probes are available but cell culture 60–62 
complicates the application as culture affects T-tubule ultrastructure.  
Our biochemical characterization of RyR and CaMKII modifications remains limited. No differences were found 
for the direct oxidation of RyR between SHAM and MI tissues (Supplemental Figure 14A). Immunostainings for 
both phosphorylation and oxidation of CaMKII showed a significant increase in MI myocytes (Supplemental 
Figure 14B,C). These approaches are however not sufficient to detect dynamic changes during live cell 
experiments at the subcellular level. In the current experiments, we have relied on pharmacological tools and 
despite the use of different agents and controls, there is always the potential for non-selective or indirect effects. 
This limitation was preferred over gene manipulation that requires cell culture, introducing other potential 
confounders.  
In the present work, a fraction of nearly 20% of non-coupled RyRs was observed in SHAM pig myocytes using 
functional and immunostaining methods (Supplemental Figure 1). This is high compared to studies in human 
tissues, including present data, and dog myocytes 35,63. Species-specific and methodological differences might 
account for some of this apparent disparity. Here and in our previous work 19, we predominantly rely on the 
relationship between SR Ca2+ release and TATS distance to identify RyR subgroups. If not all RyRs are active this 
may introduce discrepancies.  
 
Conclusion 
In HF and after MI, RyR microdomain organization enhances spontaneous Ca2+ release and sparks from non-
coupled sites, dependent on CaMKII activation and mito-ROS production. This specific modulation may generate 
a substrate for arrhythmia that appears to be responsive to selective pharmacologic modulation. 
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Figure legends 
 
Figure 1. Myocyte hypertrophy and increased fraction of non-coupled release sites with an increased spark 
frequency in human HF.  
(A) Cell size and TATS characteristics in non-HF (ncells=27-31;Nhumans=4) and HF (ncells=83-91;nhumans=5). Data are 
presented as mean value per subject. (B) Left. Examples of confocal line scan recording of Ca2+ transients in non-
HF and HF. Middle & right. Distribution and quantification of TF50 of the Ca2+ transient in coupled (< 14.5ms) and 
non-coupled (> 21.5ms) sites in non-HF (ncells=18;Nhumans=4) and HF (ncells=32;Nhumans=5) . (C) Left. Example of a 
confocal line scan recording using TF50 of the Ca2+ transient to assign sparks to different release sites. Middle. 
Spark frequency in coupled and non-coupled sites in non-HF (ncells=22;Nhumans=4) and Right. HF  
(ncells=32;Nhumans=6). (* p-value < 0.05;** p-value < 0.01;*** p-value < 0.001). 
 
Figure 2. CaMKII inhibition normalized both RyR activity and Ca2+ transients in human HF myocytes. 
(A) The effect of AIP in coupled and non-coupled sites in non-HF (ncells=19;Nhumans=4) and HF (ncells=23;Nhumans=6). 
(B) Ca2+ transient amplitude in non-HF (ncells=19;Nhuman=4) and HF (ncells=25;Nhuman=6) at 2 Hz stimulation with 
examples of line scan and reduced synchrony. The fraction of the scan line with at least half-maximal Ca2+ release 
as a function of time. SR Ca2+ content in non-HF and HF at 0.5 Hz (ncells=8;Nhumans=4 in non-HF; ncells=16;Nhumans=6 
in HF) and 2 Hz (ncells=11;Nhumans=4 in non-HF; ncells=20;Nhumans=6 in HF). (C) Ca2+ transient amplitude in non-HF 
(ncells=19;Nhuman=4) and HF (ncells=25;Nhuman=6) at 2 Hz and the effect with AIP (non-HF: ncells=19;Nhuman=4 and HF: 
ncells=23;Nhuman=6). (* p-value < 0.05;** p-value < 0.01;*** p-value < 0.001).  
 
Figure 3. CaMKII-dependent and ROS-dependent signaling examined at coupled vs. non-coupled sites after MI 
in pig ventricular myocytes.  
(A) Left. The effect of AIP in coupled sites in MI (ncells=16;Npigs=7) and SHAM (ncells=15;Npigs=4). Right. The effect 
of gp91 ds-tat peptide in coupled sites in MI (ncells=14;Npigs=4) and SHAM (ncells=13;Npigs=4). (B) Left. The effect of 
AIP in non-coupled sites in MI (ncells=16;Npigs=7) and SHAM (ncells=15;Npigs=4). Right. The effect of NAC in non-
coupled sites in MI (ncells=10;Npigs=5) and SHAM (ncells=10;Npigs=3) myocytes. (* p-value < 0.05;** p-value < 0.01). 
 
Figure 4. Ca2+ and ROS in the dyadic cleft after MI in pig myocytes.  
(A) a. Example of a confocal image of a pig ventricular myocyte stained for RyR (blue), CaMKII (green) and NCX 
(red). The co-localization of CaMKII in coupled and non-coupled RyRs is shown using the Manders’ coefficient in 
SHAM (ncells=26;Npigs=6) and MI (ncells=32;Npigs=7). b. Example of tissue samples in SHAM and MI stained for gp91 
(red), NCX (green) and overlay (yellow). Error bar equals 5 µm. (B) Example and mean values of ICaL inactivation 
in SHAM (ncells=19;Npigs=3) and MI (ncells=24;Npigs=5). (C) The effect of L-NAME (ncells=14;Npigs=4) and L-VNIO 
(MI:ncells=15;Npigs=4; SHAM:ncells=12;Npigs=3) in coupled sites in MI and SHAM (* p-value < 0.05;** p-value < 
0.01;*** p-value < 0.001). 
 
Figure 5. Mito-ROS microdomain affects non-coupled sites after MI in pig myocytes.  
(A) The effect of mitoTEMPO on spark frequency in coupled and non-coupled sites in MI (ncells=14;Npigs=4) and 
SHAM (ncells=13;Npigs=5). (B) a. Example traces of NAD(P)H and FAD signals, measured over time as the mean 
fluorescence intensity, in SHAM and MI cellsat 2 Hz. b. For each cell, the FAD/NAD(P)H ratio measured after 
pacing at 2 Hz was normalized to the rest value. The graph represents the frequency distribution with the fitted 
Gaussian curves in SHAM and MI. (* p-value < 0.05;*** p-value < 0.001). 
 
Figure 6. Ca2+ wave frequency increases and Ca2+ wave origin shifts towards non-coupled release sites after MI 
in pig myocytes. 
 (A). An example of Ca2+ waves for SHAM and MI is shown. (B) Wave frequency (SHAM:ncells=59;Npigs=13, 
MI:ncells=62;Npigs=16), wave-induced Ca2+ transient amplitude (SHAM:nwaves=30 in ncells=25 in Npigs=9;MI:nwaves=49 
in ncells=38 in Npigs=11) and wave-induced INCX (SHAM:nwaves=59 in ncells=32 in Npigs=9; MI:nwaves=91 in ncells=38 in 
Npigs=11) for SHAM and MI. (C) DAD incidence, DAD amplitude and spontaneous APs in SHAM (ncells=28; Npigs=6)  
and MI (ncells=34; Npigs=7) myocytes. (D) Left. Waves are assigned to coupled or non-coupled release sites by using 
the wave origin (pixel-based) and TF50 of the Ca2+ transient. Middle. The distribution of wave origins and Right. 
wave frequency in SHAM (ncells=39;Npigs=9) and MI (ncells=62;Npigs=16). (E) a. Example and quantification of 
colliding and single waves in SHAM and MI. b. Ca2+ wave peak INCX and integrated INCX in coupled and non-coupled 
sites in SHAM and MI. Colliding waves are indicated in green. Only colliding waves are included when originating 
from only coupled or non-coupled sites. (nwaves=11-28,ncells=32-38,Npigs=9-11). (* p-value < 0.05;** p-value < 
0.01;*** p-value < 0.001). 
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Figure 7. Non-coupled release sites are more sensitive to RyR blockers and inhibition of RyR modulators after 
MI in pig myocytes. (A) Effects of flecainide (SHAM: ncells=27;Npigs=5; MI: ncells=26;Npigs=6), S107 (SHAM: 
ncells=19;Npigs=3; MI: ncells=27;Npigs=4), AIP (SHAM: ncells=22;Npigs=3; MI: ncells=25;Npigs=9) and mitoTEMPO  (MI: 
ncells=23;Npigs=5) on (A) wave frequency and (B) global Ca2+ transient in SHAM and MI . (* p-value < 0.05;** p-
value < 0.01). 
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